Kris Thiruvillakkat, Global Market Access Strategist, Pfizer
Kris Thiruvillakkat works in the Patient and Health Impact business at Pﬁzer. He leads and assists global market access strategy development for pipeline assets within Pﬁzer Vaccines. Kris uncovers environmental and Payer insights across geographies as well as informing value evidence generation approaches, evidence to communication translation, price value demonstration, policy initiatives and innovative agreements among other tools with the objective of optimizing patient centric access for the emerging Vaccines portfolio. Previously, Kris managed price/offer contract opportunities with government, private Payers across Asia Paciﬁc and Canada in partnership with country and region afﬁliates.
Kris has over 20 years of experience in roles spanning market access, brand marketing, business analysis, commercial operations and account management for the biopharmaceutical industry. His commercial experience and interest encompass the specialty care medicine space- oncology, hematology, vaccines and acute care interventions. Kris completed a B.S. at Rutgers Business School and CPE certiﬁcate in Health Economics and Outcomes Research at University of Washington.